Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ГНЦ социальной и судебной психиатрии им. В.П.Сербского, Москва
Список исп. литературыСкрыть список 1. Смулевич А.Б., Дробижев М.Ю., Иванов С.В. Транквилизаторы – производные бензодиазепина в психиатрии и общей медицине. М.: Хоффманн-Ля Рош, 1999. 2. Kostowsky W. Бензодиазепины: механизмы действия и применение (В.Костовски). Warszawa: Chemil, 1988. 3. Schmidt R, Wernado M. Зависимости. В кн.: Психиатрия, психосоматика, психотерапия (Шмидт Р., Вернадо М.). Алетейя (пер. с нем.). М., 1991. 4. Covi L et al. Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiat Scand 1973; 49 (1): 51–64. 5. Hallstrom C, Lader M. Benzodiazepine withdrawal phenomena. Int Pharmacopsychiat 1981; 16 (4): 235–44. 6. Laughren TP et al. A controlled trial of diazepam withdrawal in chronically anxious outpatients. Acta Psychiat Scand 1982; 65 (3): 171–9. 7. Rickels K et al. Long-term diazepam therapy and clinical outcome. JAMA 1983; 250 (6): 767–71. 8. Betts TA, Birtle J. Effect of two hypnotic drugs on actual driving performance next morning. Br Med J (Clin Res Ed) 1982; 285 (6345): 852. 9. Hockings N, Ballinger BR. Hypnotics and anxiolytics. Br Med J (Clin Res Ed) 1983; 286 (6382): 1949–51. 10. Lader MH, Petursson H. Benzodiazepine derivatives--side effects and dangers. Biol Psychiat 1981; 16 (12): 1195–201. 11. Griffiths RR et al. Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects. Psychopharmacology (Berl) 1984; 84 (2): 147–54. 12. Dietch JT, Jennings RK. Aggressive dyscontrol in patients treated with benzodiazepines. J Clin Psychiat 1988; 49 (5): 184–8. 13. Lader MH, Ron M, Petursson H. Computed axial brain tomography in long-term benzodiazepine users. Psychol Med 1984; 14 (1): 203–6. 14. Grandison L. Actions of benzodiazepines on the neuroendocrine system. Neuropharmacology 1983; 22 (12B): 1505–10. 15. Ashton H. Benzodiazepine withdrawal: an unfinished story. Br Med J (Clin Res Ed) 1984; 288 (6424): 1135–40. 16. Ashton H. Adverse effects of prolonged benzodiazepine use. Adverse Drug React Bull 1986; 118: 440–3. 17. Bowden CL, Fisher JG. Safety and efficacy of long-term diazepam therapy. South Med J 1980; 73 (12): 1581–4. 18. Madalena JC. A Brazilian contribution to benzodiazepine psychopharmacology: research on anticonvulsant therapeutics and the dependence problem, in Benzodiazepines today and Tomorrow (proceedings of the 1st International Symposium on Benzodiazepines in Rio de Janeiro, September 1979), R.G.Priest et al., Editors. Lancaster: MTP Press Limited, 1980; p. 233–40. 19. Marriott S, Tyrer P. Benzodiazepine dependence. Avoidance and withdrawal. Drug Saf 1993; 9 (2): 93–103. 20. Miller NS, Gold MS. Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence. Am Fam Physician 1998; 58 (1): 139–46. 21. Murphy SM, Tyrer P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. Br J Psychiat 1991; 158: 511–6. 22. Roy-Byrne PP, Hommer D. Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. Am J Med 1988; 84 (6): 1041–52. 23. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1983; 1 (8339): 1402–6. 24. Lader M. Long-term anxiolytic therapy: the issue of drug withdrawal. J Clin Psychiat 1987; 48 (Suppl.): 12–6. 25. Lupolover R, Dazzi H, Ward J. Rebound phenomena: results of a 10 years\' (1970–1980) literature review. Int Pharmacopsychiat 1982; 17 (4): 194–237. 26. Linsen SM, Breteler MHM, Zitman FG. Defining benzodiazepine dependence: the confusion persists. Eur Psychiat 1995; 10: 306–11. 27. Авруцкий Г.Я. и др. Биологическая терапия психических заболеваний. Л.: Медицина, 1975. 28. Romach M et al. Clinical aspects of chronic use of alprazolam and lorazepam. Am J Psychiat 1995; 152 (8): 1161–7. 29. Woods JH, Katz JL, Winger G. Use and abuse of benzodiazepines. Issues relevant to prescribing. JAMA 1988; 260 (23): 3476–80. 30. Lucki I, Rickels K. The behavioral effects of benzodiazepines following long-term use. Psychopharmacol Bull 1986; 22 (2): 424–33. 31. Lucki I et al. Behavioral effects of alprazolam in chronic therapeutic users. NIDA Res Monogr 1989; 95: 464. 32. Ashton H. Benzodiazepine Withdrawal: Outcome in 50 Patients. Brit J Addict 1986; 82: 655–71. 33. Hawley CJ et al. Comparison of long-term benzodiazepine users in three settings. Br J Psychiat 1994; 165 (6): 792–6. 34. Higgitt A et al. Group treatment of benzodiazepine dependence. Br J Addict 1987; 82 (5): 517–32. 35. Hellerstein DJ et al. A clinical profile of patients affected by state regulation of benzodiazepine prescriptions. Hosp Community Psychiat 1994; 45 (4): 362–5. 36. Helman CG. «Tonic», «fuel» and «food»: social and symbolic aspects of the long-term use of psychotropic drugs. Soc Sci Med [B] 1981; 15 (4): 521–33. 37. Taylor KM, Laverty R. The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of the rat brain. Eur J Pharmacol 1969; 8 (3): 296–301. 38. British National Formulary No 31., B.M.a.a.R.p.s.o.G. Britain, Editor. 1996. 39. Lelliott PT et al. Agoraphobics 5 years after imipramine and exposure. Outcome and predictors. J Nerv Ment Dis 1987; 175 (10): 599–605. 40. Пятницкая И.Н. Наркомании. М.: Медицина, 1994. 41. Семке В.Я. (ред). Актуальные вопросы пограничных и аддиктивных состояний. Томск–Барнаул, 1998. 42. Mant A et al. Insomnia in general practice. Results from NSW General Practice Survey 1991–1992. Aust Fam Physician 1996; Suppl. 1: S15–8. 43. Sammers J, Brown B. Benzodiazepine prescribing in psychiatric hospital. Psychiatric Bull 1998; 22 (6): 480–3. 44. Garretty DJ et al. Benzodiazepine misuse by drug addicts. Ann Clin Biochem 1997; 34 (Pt 1): 68–73. 45. Lee KK et al. Use and abuse of benzodiazepines in Hong Kong 1990–1993 – the impact of regulatory changes. J Toxicol Clin Toxicol 1995; 33 (6): 597–602. 46. Herings RMC. Chronisch gebruik van slaap en kalemrings-middelen: RIVM report 319002001. Bilthoven, 1991. 47. Balter MB. Prevalence of medical use of prescription drugs, in NIDA technical review: Evaluation of the impact of prescription drug diversion control systems on medical practice and patient care: possible implications for future research. Bethesda MD: NIDA, June 1991. 48. Paton C, Banham S, Whitmore J. Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing? Psychiat Bull 2000; 24: 113–5. 49. Rickels K. Antianxiety therapy: potential value of long-term treatment. J Clin Psychiat 1987; 48 (Suppl.): 7–11. 50. Аведисова А.С. К вопросу о зависимости к бензодиазепинам. Психиат. и психофармакотер. 1999; 1. 51. AmDrugList, American Druglist. Top 200 drugs of 1995. New York, 1996; p. 18–26. 52. Egan ME et al. High daily doses of benzodiazepines among Quebec seniors: prevalence and correlates. BMC Geriatrics 2001; 1 (4).